Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
Status unconfirmed · Phase 4
Conditions studied: Bipolar I Disorder
In brief
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.
Key facts
- Study ID
- NCT00608075
- Run by
- University of Cincinnati
- People needed
- 260
- Starts
- 2007-04-01
- Expected to finish
- 2017-07-01
- Last updated by the study team
- 2016-10-06
Who can join
Age: 15 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Cincinnati — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.